☆ 4.5 Article

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3

ARTHRITIS & RHEUMATOLOGY (2021)

期刊

ARTHRITIS & RHEUMATOLOGY

卷 73, 期 2, 页码 E1-E12

出版社

WILEY

DOI: 10.1002/art.41596

关键词

类别

Rheumatology

资金

American College of Rheumatology

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

智能总结 New
摘要

Guidance on managing adult rheumatic disease during the COVID-19 pandemic was developed by a task force of rheumatologists and infectious disease specialists. Through collating clinical questions, generating an evidence report, and using a modified Delphi process, final guidance statements were approved and presented as a living document due to the rapidly evolving literature and low level of available evidence. These statements aim to promote optimal care during the current pandemic with updates anticipated in the future.

Objective To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID-19) pandemic. Methods A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included asynchronous anonymous voting by email and webinars with the entire panel. Task force members voted on agreement with draft statements using a 1-9-point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7-9, 4-6, and 1-3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus. Results Draft guidance statements approved by the task force have been combined to form final guidance. Conclusion These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a living document, and future updates are anticipated.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.5

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2

Dawn M. Wahezi, Mindy S. Lo, Tamar B. Rubinstein, Sarah Ringold, Stacy P. Ardoin, Kevin J. Downes, Karla B. Jones, Ronald M. Laxer, Rebecca Pellet Madan, Amy S. Mudano, Amy S. Turner, David R. Karp, Jay J. Mehta

Summary: The task force has approved 39 guidance statements, which were combined to form a total of 33 final guidance statements based on similar recommendations. All final statements received median vote ratings within the highest tertile of agreement and were associated with either moderate consensus (n = 5) or high consensus (n = 28).